Long Term Study With B2036-PEG
NCT00143416
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Acromegaly
Interventions
DRUG:
Pegvisomant
Sponsor
Pfizer